---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-100239"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:29:26.755821+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell shareholders OK 150M authorized share increase, reverse split, equity plan boost

## Summary
- Stockholders approved increasing authorized common shares from 100M to 250M.
- Board authorized to effect reverse stock split of 1:5 to 1:15 at any time before Sept 16, 2025.
- Equity plan share pool increased by 8M shares to 13.6M; each plan extended to 2034.
- All seven director nominees elected; Brightman Almagor Zohar & Co. ratified as auditor.
- Advisory vote on executive compensation approved with a 3-year frequency for future votes.

## SEC filing metadata
- accession: 0001104659-24-100239
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465924100239/0001104659-24-100239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465924100239/tm2424130d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-100239
- JSON: https://secwatch.observer/filing/0001104659-24-100239.json
- Plain text: https://secwatch.observer/filing/0001104659-24-100239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.